Skip to content

Updated guide shows which countries restrict entry and residence for people with HIV

AZT, 3TC and efavirenz: a tolerable first-line regimen for South African men

Rapid, opt-out HIV testing accepted by over 99% of women in an urban Malawi program

Interaction between efavirenz and phenytoin can result in undetectable blood levels of efavirenz

Effects of adherence support programmes may be short lived

Injection drug use, low baseline CD4 counts continue to predict poorer HAART response after six years

Managing meningitis in people with HIV in resource-limited settings: a clinical review

Atazanavir pharmacokinetics not appreciably altered during late-stage pregnancy

Existing metabolic syndrome predicts cardiovascular disease and diabetes in HIV-positive people starting anti-HIV treatment